CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience

Background: Aromatase inhibitors (AIs) are associated with musculoskeletal pain in one third (20–47%) of breast cancer patients. Recently, CDK4/6 inhibitors have emerged as a new therapeutic approach in hormone receptor (HR)-positive breast cancer. While hematological and gastrointestinal toxicities...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrikopoulou, Angeliki, Fiste, Oraianthi, Apostolidou, Kleoniki, Skafida, Efthymia, Markellos, Christos, Liontos, Michalis, Kyriazoglou, Anastasios, Dimopoulos, Meletios-Athanasios, Zagouri, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293403/
https://www.ncbi.nlm.nih.gov/pubmed/34198899
http://dx.doi.org/10.3390/medsci9020042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293403/
https://www.ncbi.nlm.nih.gov/pubmed/34198899
http://dx.doi.org/10.3390/medsci9020042

Ejemplares similares